SciSparc (NASDAQ:SPRC) Shares Down 2.8% – Time to Sell?

SciSparc Ltd. (NASDAQ:SPRC) shares were down 2.8% during mid-day trading on Friday . The company traded as low as $2.07 and last traded at $2.1570. Approximately 432,494 shares were traded during trading, a decline of 83% from the average daily volume of 2,584,038 shares. The stock had previously closed at $2.22.

Analysts Set New Price Targets

A number of brokerages recently weighed in on SPRC. Weiss Ratings reissued a “sell (e+)” rating on shares of SciSparc in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of SciSparc to a “sell” rating in a research report on Saturday, September 13th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, SciSparc presently has an average rating of “Sell”.

SciSparc Trading Down 2.8%

The company’s fifty day moving average price is $3.59 and its 200-day moving average price is $4.93.

SciSparc Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution.